ORA Biosimilar Position Statement

A rheumatologist’s decision to prescribe a biologic agent (biosimilar or innovator molecule) must be informed by the clinical need and must adhere to the principles of a sound therapeutic alliance. The Ontario Rheumatology Association (ORA) is aware that automatic (non-medical) switching from innovator to biosimilar molecule may achieve cost-savings to the health care system. […]

Read More…


Employment Standards in Ontario – What You Need to Know

The Employment Standards Act, 2000 (ESA) protects employees and sets minimum standards for most workplaces in Ontario. Employers are prohibited from penalizing employees in any way for exercising their ESA rights. […]

Read More…


Insurance Tips from the ORA

Below are facts about Insurance that you might not know! it is possible to have different Insurance plans from the same Insurance company i.e. not all Sunlife plans are the same. Some could […]

Read More…